Publications
Click on a title to open the PDF. You will need Adobe Acrobat Reader installed on your computer to view the PDF files. If you do not have Adobe Acrobat Reader, you can download it from here.| 76 | Altered oesophageal motility following the administration of the 5HT 1 agonist, sumatriptan. | |
| Foster JM, Houghton LA, Whorwell PJ. | Alimentary Pharmacology and Therapeutics 1999;13:927-36. | |
| 77 | Design of treatment trials for functional gastrointestinal disorders. | |
| Veldhuyzen Van Zanten SJ, Talley NJ, Bytzer P, Klein KB, Whorwell PJ, Zinsmeister AR. |
Gut 1999;45(suppl II):II69-II77. | |
| 78 | Increased prevalence of sicca complex and fibromyalgia in patients with irritable bowel syndrome. | |
| Barton A, Pal B, Whorwell PJ, Marshall D. | American Journal of Gastroenterology 1999;94:1898-901. | |
| 79 | New drug profile - tegaserod, a viewpoint. | |
| Whorwell PJ. | Drugs 1999;58:497-8. | |
| 80 |
5HT 4 receptor antagonism in irritable bowel syndrome: effect of SB-207266-A on rectal sensitivity and small bowel transit. |
|
| Houghton LA, Jackson NA, Whorwell PJ, Cooper SM. | Alimentary Pharmacology and Therapeutics 1999;13:1437-44. | |
| 81 | Hypnosis for irritable bowel syndrome. | |
| Whorwell PJ. | E Corazziari, editor. Approach to the Patient with a Chronic Gastrointestinal Disorder . Chapter. Milan: Messaggi; 2000. p. 537-44. | |
| 82 | Nongastrointestinal disorders in the irritable bowel syndrome. | |
| Azpiroz F, Dapoigny M, Pace F, Muller-Lissner S, Coremans G, Whorwell PJ, Stockbrugger RW, Smout A. |
Digestion 2000;62:66-72. | |
| 83 | Design of treatment trials in functional bowel disorders. | |
| Van Zanten S, Talley NJ, Whorwell PJ. | Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE, editors. Rome II - The Functional Gastrointestinal Disorders. Chapter 11. McLean VA: Degnon Associates; 2000. | |
| 84 |
Alosetron, a 5HT 3 receptor antagonist, delays colonic transit in patients with irritable bowel syndrome and healthy volunteers. |
|
| Houghton LA, Foster JM, Whorwell PJ. | Alimentary Pharmacology and Therapeutics 2000;14:775-82. | |
| 85 | The problem of gas in irritable bowel syndrome. | |
| Whorwell PJ. | American Journal of Gastroenterology 2000;95:1618-9. | |
| 86 | Why people with IBS may need to ban the bran. | |
| Whorwell PJ. | Health and Ageing 2000;20-2. | |
| 87 | Gynaecological aspects of irritable bowel syndrome. | |
| Whorwell PJ. | Practical Gastroenterology 2000;24:21-4. | |
| 88 | Potential pitfalls in the differential diagnosis of irritable bowel syndrome. | |
| Smout A, Azpiroz F, Coremans G, Dapoigny M, Collins S, Muller-Lissner S, Pace F, Stockbrugger RW, Vatn M, Whorwell PJ. |
Digestion 2000;61:247-56. | |
| 89 | Functional Dyspepsia and a positive diagnosis of irritable bowel syndrome. | |
| Francis CY, Whorwell PJ. | Heatley RV, editor. Dyspepsia: The Clinical Consequences . Chapter 9. Oxford: Blackwell Science Ltd; 2000. p. 111-28. | |
| 90 | Do male sex hormones protect from irritable bowel syndrome? | |
| Houghton LA, Jackson NA, Whorwell PJ, Morris J. | American Journal of Gastroenterology 2000;95:2296-300. | |